Endothelial progenitor cells and surgical outcomes

内皮祖细胞和手术结果

• 批准号: 7210310
• 负责人: ANDREW D AUERBACH
• 金额: $ 18.22万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2009-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7210310
• 关键词: Adverse effects; Age; Blood Vessels; Cardiac; Cardiovascular Diseases; Cell Count; Cessation of life; Clinical; Clinical Trials; Count; Data; Development; Disease; Electrocardiogram; Endothelium; Event; Functional disorder; Future; Hour; Incidence; Intervention; Ischemia; Knowledge; Longevity; Measures; Medical center; Modality; Myocardial; Myocardial Infarction; Numbers; Nursing Homes; Operative Surgical Procedures; Outcome; Patients; Population; Postoperative Period; Recovery; Risk; Role; Stem cells; Stratification; Telephone; Therapeutic; Tissues; Troponin; adult stem cell; cerebrovascular; day; experience; follow-up; improved; indexing; mortality; older patient; prospective; therapy design

DESCRIPTION (provided by applicant): As the population continues to age, the number of elderly patients who are candidates for surgery will rise dramatically. Many of them will derive quality and length of life benefits from their surgery. Others will experience complications, placing them at higher risk for discharge to a nursing home, an outcome associated with an increased risk for death. Better understanding of factors influencing outcomes following surgery is important for two reasons. First, it can help guide candidacy for elective surgery by identifying patients in whom the risks of surgery likely exceeds the benefits. Second, improved risk predictions can identify patients in whom interventions designed to improve outcomes may be indicated. Endothelial progenitor cells (EPCs) are a subtype of adult stem cell that appear to protect against cardiac and cerebrovascular arteriosclerotic disease through their ability to generate endothelium and neovascularize ischemic tissues. These two actions are likely to have importance in patients undergoing surgery in that cardiac ischemia induced by surgery is a precipitant of myocardial infarction. Our study will extend previous observations regarding EPC's role in cardiovascular disease by determining whether EPC's are associated with risk for postoperative myocardial infarction. We propose a 2 year prospective trial of 125 patients undergoing vascular surgery at UCSF Medical Center, in whom we will collect pre-and postoperative data regarding EPC count and function, determine the incidence of cardiac events using clinically objective measures (e.g. ECG and Troponin-l), as well as detecting additional post-discharge events through phone follow-up at 1 and 6 months. Our study's results will give a greater knowledge of the pathophysiology of recovery following major noncardiac surgery, yield understanding of how EPC's may be used - along with traditional risk indices - to aid risk stratification, as well as guide the development of future observational and clinical trials of preventative strategies using EPCs as a therapeutic modality.

描述（由申请人提供）：随着人口持续老龄化，适合手术的老年患者数量将急剧增加。他们中的许多人将从手术中获得质量和寿命的好处。其他人会出现并发症，使他们有更高的风险出院到疗养院，结果与死亡风险增加。更好地了解影响手术后结果的因素很重要，原因有二。首先，它可以通过识别手术风险可能超过收益的患者来帮助指导选择性手术的候选人资格。其次，改进的风险预测可以识别出可能需要进行旨在改善结局的干预的患者。内皮祖细胞（Endothelial progenitor cells，EPCs）是成体干细胞的一个亚型，通过其生成内皮细胞和使缺血组织新生血管的能力来预防心脑血管疾病。这两种作用在手术患者中可能具有重要性，因为手术诱导的心肌缺血是心肌梗死的促发因素。我们的研究将通过确定EPC是否与术后心肌梗死的风险相关来扩展先前关于EPC在心血管疾病中的作用的观察。我们提出了一项为期2年的前瞻性试验，125例患者在UCSF医疗中心接受血管手术，其中我们将收集有关EPC计数和功能的术前和术后数据，使用临床客观指标（例如ECG和肌钙蛋白-I）确定心脏事件的发生率，以及通过1个月和6个月的电话随访检测其他出院后事件。我们的研究结果将使我们更好地了解重大非心脏手术后恢复的病理生理学，了解EPC如何与传统的风险指数一起沿着来帮助风险分层，并指导将来使用EPC作为治疗方式的预防策略的观察和临床试验的发展。